Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET

NCT06482307 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT06482307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06482307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET
Lead sponsor
University Medical Center Groningen
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
May 31, 2025
Completion date
February 28, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma (hnscc)